Skip to main content
. 2021 Aug 30;25:320. doi: 10.1186/s13054-021-03734-y

Table 1.

Characteristics of the phenotypes on eICU derivation cohort

Characteristic eICU derivation phenotype-I phenotype-II phenotype-III
No. of patients (%) 3875 1565 1232 1078
Age, mean (SD), years 66.0 (15.5) 67.3 (14.6) 61.2 (16.7) 69.6 (13.9)
Gender—female, No. (%) 1825 (47.1%) 787 (50.3%) 593 (48.1%) 445 (41.3%)
Past history
 Hypertension (%) 2177 (56.7%) 905 (58.4%) 569 (46.6%) 703 (65.6%)
 Insulin-dependent diabetes (%) 608 (15.8%) 228 (14.7%) 131 (10.7%) 249 (23.2%)
 COPD (%) 975 (25.4%) 506 (32.7%) 223 (18.3%) 246 (22.9%)
 CABG (%) 248 (6.5%) 102 (6.6%) 47 (3.8%) 99 (9.2%)
APACHE IV Score, mean (SD) 62.6 (26.1) 52.6 (20.5) 65.4 (27.6) 74.2 (26.3)
Berlin classification*
 Mild (%) 424 (25.0%) 185 (27.2%) 106 (19.5%) 133 (28.4%)
 Moderate (%) 743 (43.9%) 345 (50.7%) 217 (39.9%) 181 (38.6%)
 Severe (%) 526 (31.1%) 150 (22.1%) 221 (40.6%) 155 (33.0%)
Temperature, mean (SD), °C 37.3 (0.8) 37.0 (0.6) 37.8 (0.9) 37.0 (0.7)
Heart rate, mean (SD), BPM 104.2 (22.7) 97.4 (19.0) 117.5 (22.2) 98.8 (21.3)
Respiratory rate, mean (SD), breaths/min 28.6 (8.3) 26.3 (7.1) 32.6 (9.1) 27.4 (7.1)
Systolic blood pressure, mean (SD), mm Hg 102.2 (21.9) 109.6 (21.5) 96.6 (18.9) 98.3 (23.0)
Glasgow Coma Scale score, mean (SD) 12.3 (3.7) 13.1 (3.2) 11.4 (4.1) 12.1 (3.6)
Potassium, mean (SD), mg/L 4.1 (0.7) 4.1 (0.6) 3.7 (0.5) 4.5 (0.7)
Sodium, mean (SD), mg/L 137.5 (5.7) 137.9 (5.3) 137.9 (6.0) 136.3 (5.7)
Glucose, median (IQR), mg/dL 131.0 (107.0–168.0) 134.0 (110.0–170.0) 125.0 (104.0–153.0) 135.0 (105.0–185.0)
Hematocrit, mean (SD), g/dL 33.8 (7.2) 37.3 (6.5) 32.3 (6.7) 30.6 (6.4)
Creatinine, median (IQR), mg/dL 1.2 (0.8–1.9) 1.0 (0.7–1.3) 1.0 (0.7–1.4) 2.6 (1.8–4.4)
Blood urea nitrogen, median (IQR), mg/dL 24.0 (16.0–39.0) 20.0 (14.0–28.0) 18.0 (12.0–27.0) 50.0 (36.0–67.0)
Bicarbonate, mean (SD), mmol/L 25.3 (6.4) 29.3 (5.8) 23.4 (5.1) 21.5 (5.2)
Platelets, median (IQR), × 109 /L 206.0 (150.0–275.0) 217.0 (171.8–286.2) 196.0 (131.0–264.0) 191.0 (129.0–265.0)
White blood cell count, median (IQR), × 109 /L 11.6 (8.2–16.1) 10.9 (8.1–14.6) 12.4 (8.5–17.5) 12.1 (8.3–17.0)
Albumin, mean (SD), g/dL 2.9 (0.7) 3.3 (0.6) 2.7 (0.7) 2.8 (0.7)
Total Bilirubin, median (IQR), mg/dL 0.6 (0.4–1.0) 0.5 (0.4–0.8) 0.7 (0.5–1.2) 0.7 (0.4–1.2)
PaO2, mean (SD), mm Hg 73.0 (59.0–97.0) 74.0 (60.0–95.0) 71.0 (58.0–96.0) 75.4 (59.6–100.0)
PaCO2, mean (SD), mm Hg 41.0 (34.0–51.0) 51.0 (42.5–65.0) 36.0 (31.0–41.0) 38.0 (31.0–45.0)
pH, mean (SD), unit 7.3 (0.1) 7.3 (0.1) 7.4 (0.1) 7.3 (0.1)
In-hospital days, median (IQR), d 6.0 (3.0–11.0) 5.0 (3.0–9.0) 7.0 (4.0–13.0) 6.0 (3.0–11.0)
In-hospital mortality, No. (%) 572 (14.8%) 117 (7.5%) 219 (17.8%) 236 (21.9%)

eICU, telehealth intensive care unit; APACHE, Acute Physiology and Chronic Health Evaluation; CABG, coronary artery bypass graft; COPD, chronic obstructive pulmonary disease; BPM, beats per minute; SD, standard deviation; IQR, interquartile range; PaO2, partial pressure of oxygen; PaCO2, partial pressure of carbon dioxide; WBC, white blood cell count

*Berlin classification for 1693 patients with valid arterial blood gas (ABG) test in eICU derivation cohort

In-hospital days calculated as the time difference in days between ICU admission and hospital discharge